ADMA Biologics Investor Relations Material
Latest events
Q1 2025
ADMA Biologics
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from ADMA Biologics Inc
Access all reports
ADMA Biologics Inc. is a biopharmaceutical company specializing in the development, manufacturing, and commercialization of plasma-derived products. The company focuses on producing and marketing therapies for patients with immune deficiencies and other immune-compromised conditions. ADMA Biologics' product portfolio includes immunoglobulin therapies that help prevent infections in individuals with weakened immune systems. In addition to developing its own products, the company operates plasma collection centers to support its manufacturing needs and ensure a stable supply of raw materials. The company is headquartered in Ramsey, New Jersey, and its shares are listed on the Nasdaq Stock Market.
Latest articles
)
Lowe's Companies: Building a One-Stop Shop for Home Improvement
Lowe's Companies began as a single store in 1921 and has steadily expanded its footprint and offerings, now operating 1,750 stores across the U.S.
7 May 2025
)
Greg Abel: Succeeding Warren Buffett at Berkshire Hathaway
After decades working with Warren Buffett and Charlie Munger, Greg Abel was named Buffett’s successor as he steps down in late 2025.
5 May 2025
)
Intuitive Surgical: Enhancing Surgery with Robotic Precision
Intuitive Surgical has revolutionized surgery with robotics, building its dominant position through decades of innovation, validation, and expansion.
2 May 2025
Ticker symbol
ADMA
Country
🇺🇸 United States